Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 2/20 | 0.66 |
| ▸ | CTSB | P07858 | 2/20 | 0.66 |
| ▸ | F3 | P13726 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | MAPT | P10636 | 5/20 | 0.52 |
| ▸ | RAB9A | P51151 | 4/20 | 0.52 |
| ▸ | MAOB | P27338 | 3/20 | 0.52 |
| ▸ | MAOA | P21397 | 2/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.52 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.51 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.51 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25196799 | 1.00 | CTSL (0.66) | CTSLCTSBF3ALDH1A1MAPT | |
| SCHEMBL25191350 | 0.91 | ALDH1A1 (0.71) | CTSLCTSBALDH1A1MAPTRAB9A | |
| SCHEMBL25195117 | 0.91 | ALDH1A1 (0.71) | CTSLCTSBALDH1A1MAPTRAB9A | |
| SCHEMBL31233022 | 0.85 | MAPT (0.63) | CTSLCTSBALDH1A1MAPTRAB9A | |
| SCHEMBL30383840 | 0.85 | MAPT (0.63) | CTSLCTSBALDH1A1MAPTRAB9A | |
| SCHEMBL25204031 | 0.85 | MAPT (0.63) | CTSLCTSBALDH1A1MAPTRAB9A | |
| SCHEMBL25192707 | 0.85 | MAPT (0.63) | CTSLCTSBALDH1A1MAPTRAB9A | |
| SCHEMBL25198029 | 0.83 | ALDH1A1 (0.50) | CTSLCTSBALDH1A1MAPTRAB9A | |
| SCHEMBL25207094 | 0.83 | MKNK2 (0.55) | CTSLCTSBALDH1A1MAPTRAB9A | |
| SCHEMBL25196904 | 0.83 | ALDH1A1 (0.50) | CTSLCTSBALDH1A1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | CTSL 310/4885CTSB 60/4885F3 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.